Dr Jesse Morse explains why BPC 157 will never receive FDA approval despite its potential to accelerate healing and recovery from injuries. >> Link Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The Emerging Risk of Peptides in Supplements LegitScript The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York